Literature DB >> 16170510

[Skull base chondrosarcoma. An interdisciplinary challenge].

P U Lohnstein1, J Schipper, M Tatagiba, N-C Gellrich, A Berlis, W Maier.   

Abstract

BACKGROUND: Chondrosarcoma is a rare differential diagnosis of malignant tumours of the skull base. The prognosis was rated as unfavourable in articles for many years. It has, however, improved considerably in recent years. The objective of this study was to evaluate and current, new optimised treatment strategies. PATIENTS AND METHODS: We retrospectively analysed the case histories and course of four patients whom we treated for chondrosarcoma of the skull base over the past 5 years at the Freiburg Skull Base Centre.
RESULTS: Because of initially mild symptoms, the patients first came for examination at an advanced stage of the tumour. All patients underwent surgery, whereby an R0-resection was barely or only questionably present. Three patients underwent radiation therapy postoperatively. All patients are currently tumour free.
CONCLUSIONS: Surgical treatment with curative intent is basically the therapy of choice. Due to the usually large size of the tumour and its close relationship to relevant structures, complete resection is, however, not always possible despite advances in surgical procedures. Taking the possibility of modern adjuvant radiotherapeutic procedures into account, an incomplete, function-preserving resection is preferred to a radical and mutilating resection.

Entities:  

Mesh:

Year:  2006        PMID: 16170510     DOI: 10.1007/s00106-005-1324-0

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  35 in total

1.  Microsurgical tissue transfer and individual computer-aided designed and manufactured prefabricated titanium implants for complex craniofacial reconstruction.

Authors:  Harald Eufinger; Michael Wehmöller
Journal:  Scand J Plast Reconstr Surg Hand Surg       Date:  2002

2.  Prognostic factors in chondrosarcoma of bone: a clinicopathologic analysis with emphasis on histologic grading.

Authors:  H L Evans; A G Ayala; M M Romsdahl
Journal:  Cancer       Date:  1977-08       Impact factor: 6.860

3.  Chondrosarcoma of the skull base.

Authors:  J F Kveton; D E Brackmann; M E Glasscock; W F House; W E Hitselberger
Journal:  Otolaryngol Head Neck Surg       Date:  1986-01       Impact factor: 3.497

4.  Radiotherapy for chordomas and low-grade chondrosarcomas of the skull base with carbon ions.

Authors:  Daniela Schulz-Ertner; Thomas Haberer; Oliver Jäkel; Christoph Thilmann; Michael Krämer; Wolfgang Enghardt; Gerhard Kraft; Michael Wannenmacher; Jürgen Debus
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-05-01       Impact factor: 7.038

5.  Chondrosarcoma of the head and neck.

Authors:  B B Burkey; H T Hoffman; S R Baker; A F Thornton; K D McClatchey
Journal:  Laryngoscope       Date:  1990-12       Impact factor: 3.325

6.  Chondrosarcoma of the base of the skull: a clinicopathologic study of 200 cases with emphasis on its distinction from chordoma.

Authors:  A E Rosenberg; G P Nielsen; S B Keel; L G Renard; M M Fitzek; J E Munzenrider; N J Liebsch
Journal:  Am J Surg Pathol       Date:  1999-11       Impact factor: 6.394

7.  Chordoma and chondrosarcoma of the cranial base: an 8-year experience.

Authors:  C N Sen; L N Sekhar; V L Schramm; I P Janecka
Journal:  Neurosurgery       Date:  1989-12       Impact factor: 4.654

8.  Chondrosarcomas of the skull base: MR imaging features.

Authors:  S P Meyers; W L Hirsch; H D Curtin; L Barnes; L N Sekhar; C Sen
Journal:  Radiology       Date:  1992-07       Impact factor: 11.105

9.  Radiotherapy of chondrosarcoma of bone.

Authors:  A R Harwood; J I Krajbich; V L Fornasier
Journal:  Cancer       Date:  1980-06-01       Impact factor: 6.860

Review 10.  Experience in charged particle irradiation of tumors of the skull base: 1977-1992.

Authors:  J R Castro; D E Linstadt; J P Bahary; P L Petti; I Daftari; J M Collier; P H Gutin; G Gauger; T L Phillips
Journal:  Int J Radiat Oncol Biol Phys       Date:  1994-07-01       Impact factor: 7.038

View more
  1 in total

1.  [Therapy of posterior orbital tumors].

Authors:  W Maier; G J Ridder; J Kaminsky; A L Grosu
Journal:  Ophthalmologe       Date:  2011-06       Impact factor: 1.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.